Skip to main content
APGEHealthcare

Apogee Therapeutics Inc (APGE) Insider Trading

In the last 90 days, 1 Apogee Therapeutics Inc (APGE) insider reported no open-market purchases and 1 sale totaling $737,935. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 5, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 5, 2026Carl DambkowskiChief Medical OfficerSale5,500$134.17$737,935
Jul 8, 2026Michael Thomas HendersonChief Executive OfficerSale20,000$133.63$2,672,600
Jul 1, 2026Carl DambkowskiChief Medical OfficerSale5,500$132.74$730,070
Jun 22, 2026Carl DambkowskiChief Medical OfficerSale26,400$132.60$3,500,640
Jun 22, 2026Michael Thomas HendersonChief Executive OfficerSale80,000$132.54$10,603,200
Jun 10, 2026Michael Thomas HendersonChief Executive OfficerSale20,000$83.38$1,667,622
Jun 3, 2026Carl DambkowskiChief Medical OfficerSale5,500$78.71$432,905
May 13, 2026Michael Thomas HendersonChief Executive OfficerSale20,000$82.09$1,641,710
May 6, 2026Carl DambkowskiChief Medical OfficerSale5,500$84.14$462,784
May 1, 2026Jane HendersonChief Financial OfficerSale2,000$82.04$164,080

Common questions

APGE insider trading FAQ

Are APGE insiders buying or selling?
Over the last 90 days, APGE insiders were net sellers, reporting $0.00 of open-market purchases and $737,935 of sales.
When was the last APGE insider purchase?
No open-market insider purchase of Apogee Therapeutics Inc stock was reported in the last 90 days.
Where does APGE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Apogee Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.